SMi Group’s next annual Adaptive Designs in Clinical Trials conference is thrilled to welcome Sandeep Menon, Vice President and Head of Early Clinical Development at Pfizer Inc. onto the speaker panel for 2019.
A key topic focus in Sandeep’s presentation is statistical and design considerations in personalised medicine. He will be discussing Identifying genetic, genomic and clinical characteristics to predict patient susceptibility. Biomarkers and the challenges in their use for diagnostics and looking into selecting appropriate designs to determine biomarker performance, reliability and regulatory acceptance.
Additionally, the vice president will explore case studies for biomarker driven trials.
For those looking to attend there is currently a £200 early-bird saving.
Further information is available at: www.adaptivedesigns.co.uk/pr.com2
SMi Presents the 11th Annual Conference on…
Adaptive Designs in Clinical Trials
Date: 1-2 April 2019
Location: London, UK
Website: www.adaptivedesigns.co.uk/pr.com2
Contact Information:
For all media inquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: hsidhu@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Let’s block ads! (Why?)
Bayern Munich fought back to earn a 1-1 draw against 1. FC Köln at the…
Advanced Micro Devices Inc shares extended their recent losses on Nov 20, dropping about 6.3%…
Broadcom shares dropped by more than 11% on Friday, tumbling alongside Nvidia, AMD, and Micron…
Actor Sanjeeda Shaikh is headlining two major digital releases in late November 2026, expanding her…
Meta Platforms stock has seen sharp price movements on Wall Street as investors balance the…
The post-listing slump hammering the SpaceX share price is less about a single aborted launch…